Search Result "major adverse cardiac event"
Reducing the Risk of Major Elective Non-cardiac Surgery: Is there a Role for Levosimendan in the Preoperative Optimization of Cardiac Function?
Journal: Current Drug Targets
Volume: 10 Issue: 9 Year: 2009 Page: 863-871
Author(s): A. Morelli, C. Ertmer, P. Pietropaoli, M. Westphal
Why is the Inhibition of the Renin-Angiotensin System Effective for Preventing Cardiac Events in Patients with Coronary Risk Factors or Coronary Artery Disease?
Journal: Current Cardiology Reviews
Volume: 2 Issue: 4 Year: 2006 Page: 293-316
Author(s): Isabelle Pham, Alain Nitenberg
Drug Repurposing Using FDA Adverse Event Reporting System (FAERS)Database
Journal: Current Drug Targets
Volume: 25 Issue: 7 Year: 2024 Page: 454-464
Author(s):
Update on the Cardiac Safety of Moxifloxacin
Journal: Current Drug Safety
Volume: 7 Issue: 2 Year: 2012 Page: 149-163
Author(s): Wilhelm Haverkamp,Frank Kruesmann,Anna Fritsch,David van Veenhuyzen,Pierre Arvis
Prognostic Impact of Red Cell Distribution Width on the Development ofContrast-Induced Nephropathy, Major Adverse Cardiac Events, and Mortalityin Coronary Artery Disease Patients Undergoing Percutaneous CoronaryIntervention
Journal: Current Cardiology Reviews
Volume: 17 Issue: 6 Year: 2021 Page: 11-20
Author(s): Azka Latif,Muhammad Junaid Ahsan,Noman Lateef,Vikas Kapoor,Hafiz Muhammad Fazeel,Faryal Razzaq,Ahmad Iftikhar,Muhammad Zubair Ashfaq,Faiz Anwer,Mohsin Mirza,Amjad Kabach
The Adverse Events Rate of Endothelial Progenitor Cell Capturing Stent in the Treatment of CAD Patients
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 21 Issue: 10 Year: 2018 Page: 725-733
Author(s): Wei-Yuan Xu,Wei-Liang Tang,Min Yuan,Yong Sun,Feng Xu,Fang Peng
Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9): Impact of PCSK9 on Major Adverse Cardiac and Cerebrovascular Events
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 14 Issue: 2 Year: 2016 Page: 94-100
Author(s): Muharrem Akin,Thomas Skripuletz,L. Christian Napp,Dominik Berliner,Ibrahim Akin,Arash Haghikia,Elvan Akin,Johann Bauersachs
Editorial (Adverse Effects, Adverse Events and Side-Effects: Does the Terminology Matter?
Journal: Current Drug Safety
Volume: 6 Issue: 1 Year: 2011 Page: 1-2
Author(s): Frank M.C. Besag
Adverse Effects of Mineralocorticoid Receptor Antagonist Administration
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 4 Year: 2018 Page: 5537-5541
Author(s): Manolis S. Kallistratos,Andreas Pittaras,Iakovos Theodoulidis,Charris Grassos,Leonidas E. Poulimenos,Athanasios J. Manolis
The Possible Adverse Effects of Intramuscular Botulinum Toxin Injections and their Management
Journal: Current Drug Safety
Volume: 1 Issue: 3 Year: 2006 Page: 271-279
Author(s): A. Magid O. Bakheit